From Research Labs to AI Factories: Aixtron's Diverse Order Flow Masks Share Retreat

Aixtron's deposition equipment orders from ROHM, MIT, and Penn State highlight broad demand across power semiconductors, AI photonics, and research, even as shares fell 34% in a month. Analysts maintain bullish targets.

A wave of orders stretching from university cleanrooms to high-volume chip fabs has underscored the breadth of demand for Aixtron's deposition equipment, even as the stock has given back more than a third of its value over the past month. The Herzogenrath-based company booked new system purchases from ROHM Semiconductor, the Pennsylvania State University, the MIT Lincoln Laboratory, and optical specialist Lumentum between May and June, spanning gallium-nitride power semiconductors, advanced photonics for AI networks, and next-generation materials research.

The buying spree is not limited to one region or application. ROHM is deploying Aixtron's G10-GaN platform to expand production of gallium-nitride power devices, while Lumentum ordered multiple G10-AsP MOCVD systems to boost capacity for high-speed optical components used in AI data centers. On the research side, MIT Lincoln Laboratory selected two 300-mm Hyperion systems for work on gallium nitride and two-dimensional materials, and Penn State chose an Aixtron R&D tool as the centerpiece of its new semiconductor lab. The diversity of end markets — power electronics, optoelectronics, fundamental research — helps insulate the order book against sector-specific slowdowns.

Yet the operational momentum has done little to prop up the share price, which closed Friday at €39.43, down 34.11% over the prior 30 days. Analysts attribute the retreat partly to a sector-wide sell-off in semiconductor and AI names that overwhelmed positive company-specific news. The decline has clipped the stock 37.09% below its June peak of €62.68, though it remains well above its 200-day moving average, suggesting the longer-term uptrend is intact on a technical basis. Year-to-date, the shares still carry a gain of 124.27%.

Aixtron's first-quarter results, released in preliminary form after the period ended, showed order intake surging 30% year-on-year to €171.4 million, while revenue fell to €59.4 million from €112.5 million. The company swung to a loss per share of €0.19 versus a profit of €0.04 a year earlier, a dip management attributed to revenue timing and upfront investment. In late April, Aixtron raised its full-year revenue guidance to a range of €530 million to €590 million, up from a previous target of €520 million ±30 million, and narrowed its expected EBIT margin to between 17% and 20%. The company also placed a €450 million convertible bond in April to bolster strategic flexibility, and shareholders approved a €0.15 dividend for 2025 at the May annual meeting.

Analyst opinions remain bullish even as the stock retreats. Jefferies raised its price target to €73 on June 23, while Warburg Research lifted its target to €56 but kept a "Hold" rating. More recently, JPMorgan's Craig McDowell reaffirmed an "Overweight" stance and a €70 target on July 13, citing expected strong quarterly results and growing exposure to Asian optoelectronics clients. With the half-year report due July 30, market consensus forecasts earnings per share of €0.11 on revenue of roughly €124 million — a number that will test whether the recent price action was a mere breather after a blistering rally or the start of a more meaningful reassessment.